Patients with late-onset rheumatoid arthritis experienced greater functional impairment over 5 years, compared against those with younger-onset disease.

Dr Tom Naylor explained how "everyone thinks about hips and knees as being mostly affected, people don't think about your ...

Speaking on BBC Morning Live, discussing the often-overlooked pain, Dr Tom Naylor highlighted the significant impact of ...

An orthopaedic surgeon has said that arthritis can be "very debilitating", and it may show up in places you don’t expect. He ...

The new treatment targets inflammation directly within the joints so that therapeutic agents are released only when needed.

Shoulder symptoms led to an average of 9.6 million physician visits in 2015 and 2016 in the United States. The most common ...

Researchers are paving the way for the design of bionic limbs that feel natural to users. They demonstrate the connection ...

Nov. 13, 2024 — A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

The difference between rheumatoid arthritis and osteoarthritis must be understood so that it is diagnosed on time and appropriately treated, keeping patients' lives in the best quality possible ...